Literature DB >> 19553828

Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.

Giovanni M Boffa1, Martina Zaninotto, Riccardo Sartor, Monica Mion, Alessandra Berton, Cristina Pasqualetto, Renato Razzolini, Mario Plebani.   

Abstract

BACKGROUND: The reliability of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) as biochemical markers of heart failure in comparison to B-type natriuretic peptide (BNP) has not been investigated in depth. AIM: To compare the correlations between IL-6, TNF, BNP plasma concentrations and some clinical and instrumental variables and their prognostic value in heart failure patients.
METHODS: In 79 patients with heart failure, the correlations between IL-6, TNF and BNP plasma concentrations and a series of 18 variables were studied. Outcome events were death from any cause and combined death and heart transplantation.
RESULTS: At univariate analysis, BNP and IL-6 plasma concentrations correlated with each other (r = 0.4828; P < 0.0001), with New York Heart Association class, fluid retention, left ventricular ejection fraction, mean right atrial pressure, mean pulmonary pressure and cardiac index. All these correlations were stronger with BNP. TNF plasma concentration correlated only with New York Heart Association class and left ventricular ejection fraction.During follow-up, 1-32 months, 14 patients died and nine underwent heart transplantation. At univariate analysis, both BNP and IL-6 plasma concentrations were predictors of death and heart transplantation, but only BNP was a predictor of death; however, only creatinine plasma level was an independent predictor of prognosis.
CONCLUSION: IL-6 and TNF are less reliable biochemical markers than BNP in heart failure patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553828     DOI: 10.2459/JCM.0b013e32832ce8e2

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  4 in total

Review 1.  Biomarkers for risk prediction in acute decompensated heart failure.

Authors:  A Rogier van der Velde; Wouter C Meijers; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2014-09

2.  p21(WAF1/Cip1/Sdi1) knockout mice respond to doxorubicin with reduced cardiotoxicity.

Authors:  Jerome Terrand; Beibei Xu; Steve Morrissy; Thai Nho Dinh; Stuart Williams; Qin M Chen
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-03       Impact factor: 4.219

3.  Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.

Authors:  YanFei Qi; Vinayak Shenoy; Fong Wong; Hongwei Li; Aqeela Afzal; J Mocco; Colin Sumners; Mohan K Raizada; Michael J Katovich
Journal:  Exp Physiol       Date:  2011-06-17       Impact factor: 2.969

Review 4.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Authors:  Mark Oremus; Andrew Don-Wauchope; Robert McKelvie; Pasqualina L Santaguida; Stephen Hill; Cynthia Balion; Ronald Booth; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.